Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 3450 Records) |
| Query Trace: Lung Neoplasms and Egfr[original query] |
|---|
| A real-world study of Afatinib plus ramucirumab in treatment-naïve, EGFR-mutated, non-small cell lung cancer. BMC cancer 2023 5 23 (1): 413. Chun-Yao Huang, Hui-Li Huang, Chou-Chin Lan, Yi-Chih Huang, Yao-Kuang |
| Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer. Journal of cancer research and therapeutics 2023 5 19 (Supplement): S183-S190. Berna Komurcuoglu, Gamze Karakurt, Ozge O Kaya, Gulden Diniz, Ozgür K?rb?y?k, Aysen Evkan, Enver Yaln |
| Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations. BMC pulmonary medicine 2023 5 23 (1): 158. Jinfei Si, Yue Hao, Jingwen Wei, Jing Xiang, Chunwei Xu, Qiuping Shen, Zhengbo So |
| Comparison of First-Line Radiosurgery for Small-Cell and Non-Small Cell Lung Cancer Brain Metastases (Cross-FIRE). Journal of the National Cancer Institute 2023 5 . Chad G Rusthoven, Alyse W Staley, Dexiang Gao, Shoji Yomo, Denise Bernhardt, Narine Wandrey, Rami El Shafie, Anna Kraemer, Oscar Padilla, Veronica Chiang, Andrew M Faramand, Joshua D Palmer, Brad E Zacharia, Rodney E Wegner, Jona A Hattangadi-Gluth, Antonin Levy, Kenneth Bernstein, David Mathieu, Daniel N Cagney, Michael D Chan, Inga S Grills, Steve Braunstein, Cheng-Chia Lee, Jason P Sheehan, Christien Kluwe, Samir Patel, Lia M Halasz, Nicolaus Andratschke, Christopher P Deibert, Vivek Verma, Daniel M Trifiletti, Christopher P Cifarelli, Jürgen Debus, Stephanie E Combs, Yasunori Sato, Yoshinori Higuchi, Kyoko Aoyagi, Paul D Brown, Vida Alami, Ajay Niranjan, L Dade Lunsford, Douglas Kondziolka, D Ross Camidge, Brian D Kavanagh, Tyler P Robin, Toru Serizawa, Masaaki Yamamo |
| The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan. Frontiers in oncology 2023 5 13 1172036. Wei-Ting Chang, Hui-Wen Lin, Ting-Chia Chang, Sheng-Hsiang Lin, Yi-Heng |
| Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients. Pathology oncology research : POR 2023 5 29 1610951. Adi Horesh, Rena Pollack, Hovav Nechushtan, Rivka Dresner-Pollak, Tzahi Neum |
| Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma. Croatian medical journal 2023 5 64 (2): 84-92. Suzana Harabajsa, Hajdi Šef?i?, Marija Klasi?, Marija Milavi?, Snježana Židovec Lepej, Ivana Grgi?, Matea Zajc Petranovi?, Marko Jakopovi?, Silvana Smojver-Ježek, Petra Kor |
| Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2023 5 188 81-89. Yiquan Xu, Jingjing Yan, Chengzhi Zhou, Lin Wu, Haibo Wang, Jun Zhao, Maolin Zhou, Jingyi Wang, Xinlong Zheng, Longfeng Zhang, Kan Jiang, Xiaobin Zheng, Qian Miao, Shiwen Wu, Zihua Zou, Rong Lian, Yuange He, Rongrong Chen, Shanshan Yang, Yujing Li, Sihui Chen, Gen L |
| Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion. Lung cancer (Amsterdam, Netherlands) 2023 5 181 107233. Yingying Pan, Xinyu Liu, Wei Zhang, Wanying Wang, Haowei Wang, Libo Luo, Keyi Jia, Chuchu Shao, Shiqi Mao, Tianyu Qiu, Jun Ni, Jia Yu, Lei Wang, Bin Chen, Anwen Xiong, Guanghui Gao, Xiaoxia Chen, Fengying Wu, Caicun Zhou, Chunyan Wu, Shengxiang R |
| Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based Idylla System. Cancer control : journal of the Moffitt Cancer Center 2023 5 30 10732748231177538. Youssra Boustany, Abdelilah Laraqui, Sara El Zaitouni, Merieme Ghaouti, Asmae Benzekri, Fouad Kettani, Mohammed Oukabli, Khalid Ennibi, Bouchra Belkadi, Yassine Sekhso |
| Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting. Journal of cancer research and clinical oncology 2023 5 . Oliver Kraskowski, Jan A Stratmann, Marcel Wiesweg, Wilfried Eberhardt, Martin Metzenmacher, Kurt W Schmid, Thomas Herold, Hans-Ulrich Schildhaus, Kaid Darwiche, Clemens Aigner, Martin Stuschke, Katharina Laue, Gregor Zaun, Stefan Kasper, Jörg Hense, Martin Sebastian, Martin Schuler, Michael Pogorzels |
| Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study. Journal of thoracic disease 2023 5 15 (4): 2003-2011. Xuanting Ye, Aimi Huang, Yan Zhou, Yanbin Kuang, Weimin Wang, Aiqin Gu, Ling |
| Utilisation Patterns and Treatment Outcomes of EGFR-Tyrosine Kinase Inhibitors in EGFR-mutant Advanced Lung Carcinoma in the Pakistani-Asian Population: A Real-world Data Study. Journal of cancer & allied specialties 2023 5 9 (1): 491. Kiran Munawar, Romena Qazi, Hassan Shahryar Shei |
| The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
| Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study. Thoracic cancer 2023 5 . Chien-Yu Lin, Chia-Hao Hu, Chia-Fu Hsu, Jeng-Shiuan Tsai, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Chien-Chung L |
| Retrospective Analysis of the Incidence of Drug-Induced Interstitial Lung Disease by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Survival in Patients Aged 75 Years or Older with Lung Cancer. JMA journal 2023 5 6 (2): 182-187. Masayuki Ishibashi, Yoshiko Nakagawa, Tetsuo Shimizu, Yasuhiro Gon, Hiroshi Yamamo |
| ARID1A mutations in lung cancer: biology, prognostic role, and therapeutic implications. Trends in molecular medicine 2023 5 . Fukang Jin, Zhiguang Yang, Jingbo Shao, Jianxin Tao, Christoph Reißfelder, Sonja Loges, Lei Zhu, Sebastian Schöl |
| Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer. Cancers 2023 5 15 (9): . Rafael Rosell, Andrés Aguilar-Hernández, María González-C |
| Family Matters: Germline Testing in Thoracic Cancers. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2023 5 43 e389956. Feighanne Hathaway, Renato Martins, Steven Sorscher, Aleksandra Bzura, Frank Dudbridge, Dean A Fenne |
| The Glasgow prognostic score predicts survival in patients with advanced non-small cell lung cancer harboring sensitive EGFR mutations who are treated with EGFR tyrosine kinase inhibitors. Oncology 2023 5 . Yuki Akazawa, Satoshi Igawa, Kaori Yamada, Hiroki Yamamoto, Yuri Yagami, Nobuki Kaizuka, Hiroya Manaka, Masashi Kasajima, Yoshiro Nakahara, Takashi Sato, Hisashi Mitsufuji, Masanori Yokoba, Masaru Kubota, Jiichiro Sasaki, Katsuhiko Nao |
| Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer. EClinicalMedicine 2023 5 59 101955. G D Marijn Veerman, Rene J Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J van der Wekken, Idris Bahce, Lizza E L Hendriks, Sander Croes, Christi M J Steendam, Evert de Jonge, Stijn L W Koolen, Neeltje Steeghs, Ron H N van Schaik, Egbert F Smit, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H J Mathijss |
| Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies. BMC medicine 2023 4 21 (1): 164. Xingsheng Hu, Shucai Zhang, Zhiyong Ma, Jifeng Feng, Lin Wu, Dongqing Lv, Jianying Zhou, Xiaodong Zhang, Li Liu, Qitao Yu, Wangjun Liao, Yiping Zhang, Xiang Wang, Ying Cheng, Hongrui Niu, Ziping Wang, Dong Wang, Cheng Huang, Chunling Liu, Hui Zhao, Jian Feng, Jingzhang Li, Kejing Ying, Nong Yang, Shukui Qin, Jie Hu, Fei Liu, Yong Jiang, Nan Ge, Yuankai S |
| Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis. The oncologist 2023 4 . Chunsheng Wang, Kewei Zhao, Shanliang Hu, Wei Dong, Yan Gong, Conghua X |
| Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study. Lung cancer (Amsterdam, Netherlands) 2023 4 180 107213. Hyunwook Kim, Beung-Chul Ahn, Jiyun Lee, Jii Bum Lee, Min-Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min L |
| An association of epidermal growth factor receptor mutation subtypes with prognostic prediction and site-specific recurrence in advanced stage lung cancer patients. Molecular biology reports 2023 4 . Jigna Joshi, Apexa Pandit, Bhoomi Tarapara, Hitarth Patel, Hunayna Bhavnagari, Harsha Panchal, Franky D Sh |
| Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
| Mutant-allele dispersion correlates with prognosis risk in patients with advanced non-small cell lung cancer. Journal of cancer research and clinical oncology 2023 4 . Chen-Xu Wang, Jie Yan, Shan Lin, Yi Ding, Yan-Ru Q |
| Optimal timing of hypofractionated stereotactic radiotherapy for epidermal growth factor receptor-mutated non-small-cell lung cancer patients with brain metastases. Asia-Pacific journal of clinical oncology 2023 4 . Shimeng Liang, Xiaoqin Liu, Jia Liu, Feifei Na, Jialu Lai, Leiya Du, Youling Gong, Jiang Zhu, Meijuan Huang, Xiaojuan Zhou, Yong Xu, Lin Zh |
| A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US. Frontiers in genetics 2023 4 14 1141058. Breanna A James, Jennie L Williams, Barbara Nemesu |
| Should We Perform Repeated Re-Biopsy for the Detection of T790M Mutation? Cancer research and treatment 2023 4 . Saerom Kim, Soo Han Kim, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop E |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: